Your AI-Trained Oncology Knowledge Connection!
Reshma Jagsi, MD, DPhil is the Lawrence W. Davis Professor and chair of the Department of Radiation Oncology at Emory University School of Medicine.
Dr Jagsi on Factors for RT Omission After Breast-Conserving Surgery in Early Breast Cancer
Reshma Jagsi, MD, Dphil, discusses factors that could influence the omission of radiation therapy following breast-conserving surgery in early-stage breast cancer.
Read More
Dr Jagsi on the Implications of the IDEA Trial For Patients With Breast Cancer
Reshma Jagsi, MD, DPhil, discusses the implications of the IDEA trial for patients with breast cancer.
Dr Jagsi on the Implications of the IDEA Trial for Radiotherapy Omission in Breast Cancer
Reshma Jagsi, MD, Dphil, discusses caveats when interpreting long-term results from the IDEA trial of radiotherapy omission in breast cancer.
Dr Jagsi on the Feasibility of Radiation Omission Following Surgery in Breast Cancer Care
Reshma Jagsi, MD, DPhil, discusses 5-year findings from the IDEA trial assessing radiotherapy omission for postmenopausal patients with breast cancer.
How Genetic Testing Impacts Breast Cancer Treatment Decisions
As genetic testing becomes increasingly available, there will be a growing gap between the wide availability of testing and the relative importance of results to treatment decisions.
Reduced Radiotherapy Margins Yield Outcomes Comparable With Standard Margins in HGG
Eribulin and Trabectedin Yield Comparable Real-World OS Outcomes in Advanced Liposarcoma
Physical Functioning Measures May Predict Survival Outcomes, ICANS Risk With CAR T-Cell Therapy in NHL
First-Line Atezolizumab Is Suitable in Platinum-Based Chemotherapy Ineligible mUC